David Stroncek
Overview
Explore the profile of David Stroncek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sharma A, Leonard A, West K, Gossett J, Uchida N, Panch S, et al.
Br J Haematol
. 2022 Jun;
198(4):740-744.
PMID: 35737751
We adjusted haematopoietic stem and progenitor cell (HSPC) apheresis collection from patients with sickle cell disease (SCD) by targeting deep buffy coat collection using medium or low collection preference (CP),...
12.
Shalabi H, Qin H, Su A, Yates B, Wolters P, Steinberg S, et al.
Blood
. 2022 May;
140(5):451-463.
PMID: 35605184
Remission durability following single-antigen targeted chimeric antigen receptor (CAR) T-cells is limited by antigen modulation, which may be overcome with combinatorial targeting. Building upon our experiences targeting CD19 and CD22...
13.
Holland E, Molina J, Dede K, Moyer D, Zhou T, Yuan C, et al.
J Immunother Cancer
. 2022 May;
10(5).
PMID: 35534047
Chimeric antigen receptor T-cells (CART) are active in relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL), but relapse remains a substantial challenge. Reinfusion with the same CART product (CART2) in patients...
14.
Stroncek D, Dinh A, Rai H, Zhang N, Somerville R, Panch S
J Transl Med
. 2022 Apr;
20(1):184.
PMID: 35468789
Cellular therapies have become an important part of clinical care. The treatment of patients with cell therapies often involves the collection of autologous cells at the medical center treating the...
15.
Cortese I, Beck E, Al-Louzi O, Ohayon J, Andrada F, Osuorah I, et al.
Lancet Neurol
. 2021 Jul;
20(8):639-652.
PMID: 34302788
Background: Progressive multifocal leukoencephalopathy, a rare disease of the CNS caused by JC virus and occurring in immunosuppressed people, is typically fatal unless adaptive immunity is restored. JC virus is...
16.
Leonard A, Sharma A, Uchida N, Stroncek D, Panch S, West K, et al.
Blood Adv
. 2021 May;
5(9):2403-2411.
PMID: 33956057
Recent studies suggest that plerixafor mobilization and apheresis in patients with sickle cell disease (SCD) is safe and can allow collection of sufficient CD34+ hematopoietic stem cell (HSC) collection for...
17.
Luo Z, Li M, Mi F, Meng Z, Du G, Martin L, et al.
J Virol
. 2021 Mar;
95(11).
PMID: 33731459
Potential mechanisms of poor CD4+ T cell reconstitution after viral suppression with antiretroviral therapy (ART) in HIV disease have been extensively investigated. We recently discovered that anti-CD4 autoantibody plays a...
18.
Nagarsheth N, Norberg S, Sinkoe A, Adhikary S, Meyer T, Lack J, et al.
Nat Med
. 2021 Feb;
27(3):419-425.
PMID: 33558725
Genetically engineered T cell therapy can induce remarkable tumor responses in hematologic malignancies. However, it is not known if this type of therapy can be applied effectively to epithelial cancers,...
19.
Bae H, Liu S, Jin P, Stroncek D
Emerg Top Life Sci
. 2021 Feb;
1(5):487-492.
PMID: 33525796
Mesenchymal stem cells or mesenchymal stromal cells (MSCs) are a multipotent, heterogeneous population of cells that play a critical role in wound healing and tissue regeneration. MSCs, found in the...
20.
Mukherjee S, Reddy O, Panch S, Stroncek D
Transfus Apher Sci
. 2021 Jan;
60(1):103066.
PMID: 33472742
Cell processing laboratories are an important part of cancer treatment centers. Cell processing laboratories began by supporting hematopoietic stem cell (HSC) transplantation programs. These laboratories adapted closed bag systems, centrifuges,...